Richtlijn: Niet-kleincellig longcarcinoom (2.0) - Kwaliteitskoepel

Richtlijn: Niet-kleincellig longcarcinoom (2.0)Chi A, Liao Z, Nguyen NP, Xu J, Stea B, Komaki R. Systemic review of the patterns of failure followingstereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. RadiotherOncol 94:1-11, 2010.92 - Hotta KHotta K, Matsuo K, Ueoka H, et al: Meta-analysis of randomized clinical trials comparing cisplatin tocarboplatin in patiënts with advanced non–small-cell lung cancer. J Clin Oncol 22:3852-3859, 2004.93 - Ciuleanu TCiuleanu T, Brodowicz T, Zielinski C, et al. Maintenance pemetrexed plus best supportive care versusplacebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3study. The Lancet 374:1432-1440; 2009.94 - Clamon GClamon G, Herndon J, Cooper R, Chang AY, Rosenman J, Green MR. Radiosensitization with carboplatinfor patiënts with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer andLeukemia Group B and the Eastern Cooperative Oncology Group. J Clin Oncol 1999;17:4-11, 1999.95 - Clamon GClamon G, Herndon J, Eaton W et al. A feasibility study of extended chemotherapy for locally advancednon-small cell lung cancer: a phase II trial of Cancer and Leukemia Group B. Can Inv 12:273-282, 1994.96 - Coate LECoate LE, John TH, Tsao M-S, Shepherd FA. Molecular predictive and prognostic markers innon-small-cell lung cancer. the Lancet Oncology 10:1001 - 1010, 2009.97 - Colice GLColice GL, Rubins J, Unger M. Follow-up and surveillance of the lung cancer patiënt followingcurative-intent therapy. Chest 123:272283, 2003.98 - Begg C.B.Begg C.B., PhD; Laura D. Cramer, ScM; William J. Hoskins, MD; Murray F. Brennan, MD. Impact ofHospital Volume on Operative Mortality for Major Cancer Surgery. JAMA 280:1747-1751, 1998.99 - Commissie Beroeps UitoefeningCommissie Beroeps Uitoefening CBU. Nederlandse Vereniging voor Pathologie. Protocol Longcarcinoom.100 - NVROCommissie voor beroepsaangelegenheden van de Nederlandse Vereniging voor Radiotherapie enOncologie NVRO. Algemene normstelling voor wachttijden in de radiotherapie die uitgaande van de ‘idealesituatie’in alle afdelingen voor radiotherapie in Nederland van toepassing zou moeten zijn. Utrecht: NVRO,2002.101 - Common Therapy Evaluation Program CTEPCommon Therapy Evaluation Program CTEP. Common Toxicity Criteria. Version 2.0. DCTD, NCI, NIH,DHHS, 1998.102 - Cook GJCook GJ, Houston S, Rubens R, Maisey MN, Fogelman I. Detection of bone metastases in breast cancerby 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol16:3375-3379, 1998.103 - Sause WSause W, Kolesar P, Taylor S, Johnson D. Final results of phase III trial in regionally advancedunresectable nonsmall cell lung cancer: Radiation Therapy Oncology group, Eastern Cooperative OncologyGroup, and Southwest Oncology Group. Chest 117:358-364, 2000.104 - Corris PACorris PA, Ellis DA, Hawkins T, Gibson GJ. Use of radionuclide scanning in the preoperative evaluation ofpulmonary function after pneumonectomy. Thorax 42:285-291, 1987.06/09/2011 Niet-kleincellig longcarcinoom (2.0) 100